Duloxetine Therapy For Postherpetic Neuralgia Prevention May Reduce Occurrence Of Moderate To Severe Pain In Adults With Herpes Zoster Infection, Study Finds

Infectious Disease Advisor (1/26, Kuhns) reported, “Duloxetine therapy for the prevention of postherpetic neuralgia may reduce the occurrence of moderate to severe pain in adults with herpes zoster (HZ) infection, according to results of a study published in Clinical Infectious Diseases.” Additionally, analysis “showed that patients who received duloxetine scored significantly higher in physical and mental health examinations, and they were significantly less likely to report poor sleep quality.”